USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS IN THE RUSSIAN FEDERATION
Main Authors: | Rimma Mikhailovna Balabanova, V N Amirdzhanova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2012-12-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1174 |
Similar Items
-
Rheumatoid arthritis, osteoporosis, possibilities for the correction of bone mineral density
by: Rimma Mikhailovna Balabanova
Published: (2012-09-01) -
Leflunomide monotherapy in patients with early rheumatoid arthritis: Results of the Russian national Arava mono study
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-06-01) -
Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01) -
Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
by: Irina Mikhailovna Marusenko
Published: (2013-12-01) -
USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)